Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProQinase
Freiburg im Breisgau, Baden-Württemberg, Germany
- Ownership
- Private
- Employees
- ~33
- Development stage
- Other
01
Overview
As a CRO, ProQinase provides a comprehensive assortment of kinase-focused drug discovery services, including both biochemical/cell-based assays and in vivo oncology models, with no record of developing its own clinical drug candidates[2][3].
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeProteinBiologic
- Industry
- Drug Discovery Services
02
Partnerships
ChemDivCRELUXCell Signaling TechnologyGotham TherapeuticsBioTag Consortium (Proteome Sciences, NMI Natural and Medical Sciences Institute)
Beyond the preview
Go deeper on ProQinase.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ProQinase.